Yuan, Yue,
Han, Xuejie,
Zhao, Xinbo,
Zhang, Haiyu,
Vinograd, Asiia,
Bi, Xin,
Duan, Xiaoxu,
Cao, Yukai,
Gao, Qiang,
Song, Jia,
Sheng, Li,
Li, Yue (2024) sequelae, but its
genetic characteristic implicated in pathogenesis has not been completely clarified
Wang, Chunlei,
Beylerli, Ozal,
Gu, Yan,
Xu, Shancai,
Ji, Zhiyong,
Ilyasova, Tatiana,
Gareev, Ilgiz,
Chekhonin, Vladimir (2024) remains elusive. Aim: The aim of this study was to identify
genetic indicators of glioblastoma and reveal
molecular
genetics methods for confirming the diagnosis of NF1 in the clinic in cases of a combination
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) the significance of
genetic risk factors (carriage of major allele C of SNV rs11100494 of the NPY5R gene
Gilyazova, I.,
Ivanova, E.,
Pavlov, V.,
Khasanova, G.,
Khasanova, A.,
Izmailov, A.,
Asadullina, D.,
Gilyazova, G.,
Wang, G.,
Gareev, I.,
Beylerli, O. (2023) with complications included 84 patients. Blood samples from patients
with HFRS for molecular
genetic analysis were
Fedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) worldwide. As is known, the course of ovarian cancer depends on many factors, including
genetic